Cell and Gene Therapy MSc
Options: PG Diploma, PG Certificate
This Master's degree in Cell and Gene Therapy provides an in-depth education in this cutting edge and rapidly developing field. It is delivered by scientists and clinicians researching, developing and testing new treatments for genetically inherited and acquired diseases using gene delivery technology, stem cell manipulation and DNA repair techniques.
Mode of study
- Full-time 1 year
- Flexible 2-5 years
- UK/EU Full-time: £10,800
- Overseas Full-time: £23,700
- All applicants: 1 August 2014
More details in Application section.
What will I learn?
The degree covers all aspects of the subject, including basic biomedical science, molecular basis of disease, current and developing technologies and clinical applications. Students also receive vocational training in research methodology and statistics, how to perform a research project and in completing a practical laboratory based project.
Why should I study this degree at UCL?
The Institute of Child Health (ICH), and its clinical partner Great Ormond Street Hospital (GOSH), is the largest centre in Europe devoted to clinical and basic research and post-graduate education in children's health. ICH/GOSH is a major centre for cell therapy, including haematopoietic stem cell transplantation (HSCT) and gene therapy.
We are one of the global leaders in clinical trials of gene therapy, and we are currently conducting three clinical trials of gene therapy for three separate disorders, with clinical trials for additional disorders, including some forms of cancer, in development.
There is a strong research interest in cell and gene therapy within the School of Life and Medical Sciences (SLMS) at UCL, which has the largest concentration of clinicians and researchers active in this area of translational medicine in Europe. This is reflected by many groups conducting high-quality research and clinical trials using gene or cell therapy, including researchers in the Institute of Child Health, Division of Infection and Immunity, Institute of Ophthalmology, Institute for Women's Health, Institute of Genetics and the Cancer Institute.35
Students undertake modules to the value of 180 credits. The MSc programme consists of four core modules (60 credits), four optional modules (60 credits) and a research dissertation (60 credits).
A Postgraduate Diploma (120 credits, full-time nine months or part-time up to five years) is offered
A Postgraduate Certificate (60 credits, full-time 12 weeks or up to two years part-time) is offered.
All MSc students undertake an independent research project which culminates in a dissertation.
Teaching and Learning
Teaching includes lectures, seminars, problem classes and tutorials. Course assessment varies depending on the course, but includes written coursework, multiple-choice questions, written examinations, a practical analysis exam and the dissertation.
Further details available on subject website:
Further information about funding and scholarships can be found on the Scholarships and funding website.
Applicants should be: a qualified medical practitioner, with a qualification equivalent to a UK MB BS, a non-clinical scientist with a minimum of an upper second-class BSc or equivalent in a life or biomedical science subject; or a healthcare, pharmaceutical or biotech professional and scientist with equivalent experience (minimum 3 years).
Select your country for equivalent alternative requirements
English language proficiency level: Standard
How to apply
Students are advised to apply as early as possible due to competition for places. Those applying for scholarship funding (particularly overseas applicants) should take note of application deadlines.
The deadline for applications is 1 August 2014.
Who can apply?
The programme is designed for medics and scientists who would like to develop their knowledge in this distinct area, with a view to contributing to research and clinical trials in the field.
What are we looking for?
When we assess your application we would like to learn:
- why you want to study Cell and Gene Therapy at graduate level
- why you want to study Cell and Gene Therapy at UCL
- what particularly attracts you to this programme
- how your academic and professional background meets the demands of this challenging programme
- where you would like to go professionally with your degree
As this is a new programme no information on graduate destinations is currently available. However, a number of graduates have gone on to secure PhD places.
This novel course aims to equip students for careers in research, education, medicine and business in academic, clinical and industrial settings. Examples of potential careers could include academic research and/or lecturing in a university or other higher education setting, conducting clinical trials as part of a team of clinicians, scientists and allied health professionals, monitoring and analysing the results of clinical trials as part of a clinical trials unit, developing new therapies or intellectual property in the pharmaceutical industry or other business venture.
For queries relating to this programme, please contact:
Ms Amanda Kosinski
T: +44 (0)20 7905 2119
Apply for this programme through UCL's application portal:
Register your interest
Register your interest to keep up to date with news from UCL and receive personalised email alerts.
"My experience of graduate study at the UCL Institute of Child Health (ICH) matches the expectations I had from such a high-ranked university. The classes in my MSc had small groups of students and the lecturers were all cutting-edge experts, not only from UCL but also from other UK top universities."
Miguel Calero Garcia
Degree: Cell and Gene Therapy MSc
"One of the most beneficial aspects of being at UCL is having access to an incredible diversity of talent and expertise in virtually every field of enquiry. In my own area of neuroscience, there are over 700 neuroscientists concentrated within a small area."
Professor Faraneh Vargha-Khadem
Professor of Developmental Cognitive Neuroscience
Page last modified on 31 oct 13 16:37
Page maintained by Publications and Marketing Services